![]() |
| Volume
17, Issue 1, March 2006 |
| The
Radiation SIG Newsletter is supported through an educational
grant to ONS. |
| Coordinator's Corner SIG Workgroups Offer Exciting Opportunities Elise
Carper, RN, MA, APRN-BC, AOCN®New York, NY ecarper@chpnet.org Hello again, and happy New Year to all! After the disasters we weathered in 2006, I'm happy to start another year, hopefully without hurricanes or tsunamis. I've received many responses to my discussion on acuity and staffing in radiation oncology. Many of you are grappling with some of the same questions as I—how to "measure" the acuity of our patients, how to determine which nursing roles are needed, and how to "talk the talk" with administration to get the staffing we need. In the near future, I will contact members who have volunteered to be part of a staffing and acuity work group. Hopefully, together, we can come up with effective approaches to help us and the patients for whom we care. I'd like to remind members who have volunteered to be part of work groups in the SIG that we really do need your help. I have sent e-mail lists of members who signed up for work groups on research, legislative issues, competencies, and care plans to those who signed up at Congress 2006. Please let me know if you need my help in getting your work groups started or if I can do anything else to help you. I have exciting news about the Radiation Oncology Nurse Enhancing Excellence project, also known as RONEE, which is in the final phase of development. RONEE was conceived and implemented by a group chaired by former SIG Coordinator Marilyn L. Haas, PhD, RN, CNS, ANP-C. The project is a CD-ROM set consisting of eight modules for radiation oncology nursing education. Some modules cover generalized information such as radiation biology, the basics of radiotherapy, radiosensitizers, and radioprotectants. Others cover sites of disease (breast, prostate, etc.) and detail the cancer treatment and nursing care needed for specific disease sites, from consultation to long-term follow-up. The modules provide excellent overviews of radiation treatment and can be used to teach nurses new to radiation oncology nursing as well as to update experienced nurses on unfamiliar aspects of radiation oncology (e.g., stereotactic radiosurgery, head and neck brachytherapy, treatment of benign disease). The RONEE CD-ROM sets will be available at Congress 2006 and are a wonderful addition to resources specific to radiation oncology nursing that are already available. I speak for myself and the SIG in thanking Marilyn and all of the others involved in RONEE for their hard work and dedication to excellence. |
The
Radiation SIG Newsletter is produced by members of the Radiation SIG and ONS staff and is not a peer-reviewed publication. |
| Special Interest Group Newsletter March 2006 |
|
Nutrition and Radiation Therapy: Assessing and Addressing
Patients’ Needs I am fortunate enough to work at a cancer center that has a cancer supportive services team to address the unique needs of patients with cancer. The team consists of several social workers, a nutritionist and dietitian (myself), and a symptom management physician. The staff helps patients address a spectrum of concerns occurring throughout their treatment timelines. As for my role, nutritional consultations are a much-needed benefit to our patients, who may obtain nutritional advice and counseling before, during, and after treatment. Nutrition intervention is a valuable service that, especially when initiated early in treatment, can optimize nutritional status and improve outcomes. Additionally, nutrition education is an extremely helpful means for patients and their families to actively participate in their care. In oncology centers without staff dietitians, patients should be screened and receive general nutrition advice from RNs and other healthcare practitioners. This article provides an overview of what to look for when screening patients for nutritional risk, how to evaluate the need for nutritional supplementation, and when to refer patients for in-depth nutritional counseling with dietitians and nutritionists. Screening Screening patients will reveal their nutritional risk levels and can help staff
determine how to prioritize nutritional needs (see Figure
1). Nurses, who have primary and continued contact with patients,
have the opportunity to optimize nutrition through interventions. Nutrition
interventions can help patients maintain optimal weight, facilitate
tolerance and healing from treatment, minimize symptoms, maintain or
improve quality of life, and decrease morbidity. Having cancer can affect nutritional status in a variety of ways, even prior to treatment interventions such as surgery, chemotherapy, and radiation. Weight loss and its associated morbidity are a multifactorial problem not easily solved by getting patients to "eat more." For the sake of simplicity, this article will focus on nutritional status in patients undergoing radiation treatment (RT) (although it is never that simple). Diagnosis Cancer diagnoses and treatment fields can send up "red flags" for patients
who will receive RT to the head and neck, mediastinum, abdomen, or colorectal
regions, given the organs affected. The long list of potential nutritional
problems starts with the head and neck and works its way through the
digestive tract for this patient population, who should be closely monitored
for symptoms arising throughout treatment. Many patients with head and
neck cancers come to treatment with preexisting weight loss or oral
intake issues because of previous surgeries, dysphagia, or other swallowing
difficulties. Some patients with head and neck cancers already have
feeding tubes in place to facilitate adequate nutrition where compromised
oral routes exist. Such patients require specialized care from their
healthcare teams regarding nutritional support. Tolerance to foods can be hindered significantly in patients receiving RT to the mediastinum because of refluxing, heartburn, and, in severe cases, esophagitis. RT to the abdominal region, colon, and rectum may result in moderate to severe gastrointestinal distress in the form of nausea, gas, pain, bloating, dysmotility, malabsorption, enteritis, and diarrhea. Patients must be made aware of the normal symptoms they may experience and receive tools to minimize them, such as appropriate diets or medications. Nutritional and medical management should be implemented to minimize symptoms as they occur to prevent diminished oral intake, gastrointestinal irritation, and diarrhea. RNs can pick up on such symptoms during their daily interactions with patients or during weekly status checks. My center uses a weekly "distress thermometer" checklist on which patients record any symptoms or psychosocial concerns; the tool then is routed to appropriate staff members (e.g., nurses, social workers, nutritionists) for follow-up. Weight Weight alterations appear to have more to do with the type of cancer
rather than any cancer diagnosis. When evaluating patients' weight,
look for stable adult weight or other patterns that suggest trends over
time. Significant, unintentional weight loss is categorized as 5% or
more loss in one month or 10% or more loss in six months. Significant
weight loss with underweight status, associated with loss of appetite
and decreased lean body mass, can be considered cachexia and diminishes
treatment response while increasing morbidity and mortality. For patients
with significant weight loss, the immediate priority is to stabilize
their weight during treatment for the sake of improving treatment outcomes
(see Figure 2). Some patients
may present with a history of recent weight loss and others with longstanding
obesity, but both situations require nutritional interventions. Correcting
weight loss or staving off further depletion in high-risk patients is
an immediate priority. Patients with obesity, however, could be directed
toward nutritional counseling and exercise programs after RT is completed. Food Recall A time-efficient way to reveal inferior or inadequate intakes is to
ask patients what they usually consume in an average day. I usually
have patients go through a "normal" day, from breakfast through evening
snack. Suboptimal amounts of protein, calories, or nutrients usually
can be detected with this method. It also reveals eating patterns, cooking
frequency, and overall quality of food consumption such as empty calories
(e.g., pastries, donuts) versus nutrient-rich foods (e.g., fruits, vegetables,
lean proteins, good fats). If patients report difficulty purchasing
or cooking foods, they can be referred to social workers or to food
programs such as Meals-on-Wheels, as appropriate. Nutritional Needs Not all patients present with weight loss or malnutrition; therefore, determining nutritional needs is a dynamic process. At the very least, patients need adequate calories and protein to facilitate weight maintenance and healing. Healthcare providers should encourage patients to maintain their usual intakes of food; however, the need for adequate protein, nutrients, and fluid also must be a consideration. If cancer itself induces a hypermetabolic state, RT may further increase the body's need for calories and protein. Estimated nutritional needs are based on higher-than-normal needs for protein and calories. Sometimes, meeting such needs can be as easy as adding 500 calories per day to a patient's normal intake. Of course, dieting during RT and recovery is discouraged because it may hinder treatment outcomes (see Figure 3). Nutritional Supplements Most cancer centers have a multitude of oral meal-replacement drinks to provide to patients, such as Ensure® (Abbott Laboratories, Abbott Park, IL), Boost® (Novartis Nutrition Corporation, East Hanover, NJ), and Carnation Instant Breakfast™ (Nestlé Corporation, Glendale, CA). Most standard supplements have 250-375 calories and 9-15 grams of protein per can. I encourage patients to test different brands and flavors for tolerance and palatability. If a supplement is too dense, it can be thinned with liquid or blended into a milkshake. Patients may augment with supplements between meals or use them as meal replacements. Indications for augmenting the diet with nutritional supplements are considerable. Premade nutritional meal replacements are a quick and convenient method to maximize nutrition. Many other options exist, however, depending upon patient or caregiver ability and motivation level. I provide handouts with easy, quick, and nutritious food ideas such as savory soups, drinkable yogurts, and high-protein fruit smoothies. Most grocery stores also carry a large variety of premade pure fruit juice blends or protein-based drinks, which can contain as many calories and protein as commercial supplements. A piece of paper is not sufficient for patients who require one-on-one nutritional counseling with a registered dietician or nutritionist. If your center does not have an in-house dietitian, you can easily find one through the American Dietetics Association's Web site at www.eatright.org. Click on "Find a Nutrition Professional" and search by zip code and specialty. Clinical evidence shows that early nutritional intervention is fundamental for success in patients undergoing treatment for cancer. Nutritional intervention is a dynamic process for patients receiving RT, and healthcare providers must closely monitor how symptoms affect what or how much patients eat. Ongoing nutritional and medical management works synergistically to minimize symptoms while maximizing intakes. When patients and families are aware that good nutrition improves energy and promotes healing, they are motivated to make positive changes. The results will improve treatment outcomes and, perhaps more importantly, patients' quality of life. Bibliography Fouladiun, M., Korner, U., Bosaeus, I., Daneryd, P., Hyltander,
A., & Lundholm, K.G. (2006). Body composition and time course changes
in regional distribution of fat and lean tissue in unselected cancer
patients on palliative care—Correlations with food intake, metabolism,
exercise capacity, and hormones. Cancer, 103, 2189–2198. Larsson, M., Hedelin, B., & Athlin, E. (2003). Lived
experiences of eating problems for patients with head and neck cancer
during radiotherapy. Journal of Clinical Nursing, 12, 562–570. Laviano, A., Meguid, M.M., Inui, A., Muscaritoli, M.,
& Rossi-Fanelli, F. (2006). Therapy insight: Cancer anorexia-cachexia
syndrome—When all you can eat is yourself. Nature Clinical Practice:
Oncology, 2(3), 158–165. Mahan, L.K., & Escott-Stump, S. (2000). Krause's
food, nutrition, and diet therapy (10th ed.). Philadelphia: Saunders.
Muscaritoli, M., Bossola, M., Aversa, Z., Bellantone,
R., & Rossi Fanelli, F. (2006). Prevention and treatment of cancer cachexia:
New insights into an old problem. European Journal of Cancer, 42(1),
31–41. von Meyenfeldt, M. (2006). Cancer-associated malnutrition:
An introduction. European Journal of Oncology Nursing, 9(Suppl.
2), S35–S38.
|
| Special Interest Group Newsletter March 2006 |
|
ONS Members Conduct Pilot Study to Clinically Evaluate a Gel Product for Radiodermatitis Marilyn
L. Haas, PhD, RN, ANP-CAsheville, NC mlyhaas@worldnet.att.net Katen Moore, RN, MSN, AOCN® East Orange, NJ katen.moore@med.va.gov Of all patients undergoing radiation treatment, 95% develop radiodermatitis. Currently, no clinically proven treatment alleviates discomfort while aiding moist wound healing. This leaves nurses and doctors without an effective treatment for supportive care. RadiaPlex™ (MPM Medical Inc., Irving, TX) is a topical gel product containing hyaluronic acid and aloe vera extract. Hyaluronic acid is an active ingredient, is the most abundant compound found in normal dermal tissue, and has been shown to stimulate wound repair responses. The authors conducted a pilot study on 20 patients receiving radiation treatment for breast cancer, lung cancer, and cancers in the abdomen. Patients were evaluated while receiving radiation treatments. They were instructed to apply the RadiaPlex gel three times daily to irradiated skin during six weeks of treatment. Nurses assessed dermatitis using the National Cancer Institute's Common Toxicity Criteria and patient questionnaires designed to evaluate the product. Clinical evaluation of the gel's use indicated that 90% of patients experienced no dry desquamation or severe erythema. Eighty-five percent of patients experienced no itching, and 100% said they would recommend the gel to others. The findings regarding the clinical response to RadiaPlex were presented at a poster session at the 30th Annual ONS Congress in Orlando, FL. The initial results indicate that the gel may be effective in alleviating the desquamation that accompanies radiation therapy. RadiaPlex warrants further evaluation as an application for radiodermatitis.
|
| Special Interest Group Newsletter March 2006 |
|
The Role of Nurses in a Cyberknife® Department Nonny
Smith, BA, BSN, OCN®St. Paul, MN nsmith@healtheast.org The role of radiation nurses evolves with each advancement in radiation technology. The Radiation Therapy Department at St. Joseph's Hospital in St. Paul, MN, added a Cyberknife® (CK) (Accuray, Sunnyvale, CA) in October 2003. The institution has treated more then 500 patients with CK. This paper describes CK treatment and nurses' role in that setting. Stereotactic radiosurgery is a noninvasive and extremely precise method to deliver higher doses of radiation in a shorter period of time. CK delivers stereotactic radiosurgery from a lightweight linear accelerator mounted on a robotic arm. Fixation frames are unnecessary thanks to real-time imaging via x-ray. Consequently, treatment can be fractionated, resulting in greater safety and applicability. Precise targeting capabilities allow CK to be used for malignancies, some benign tumors, and several neurologic anomalies. Malignancies include previously irradiated tumors, solitary lung or brain lesions, and dangerously located tumors (e.g., liver, pancreatic, other abdominal masses). Neurologic problems such as acoustic neuromas, trigeminal neuralgia, meningiomas, and arterio venous malformations are among the other conditions treated with CK. Although CK originally was developed to treat intracranial lesions, both intra- and extracranial applications have been developed. Outside the skull, lesions must be marked with fiducial markers. Fiducial markers are tiny gold seeds implanted in soft tissues or tiny screws in the spine for localization prior to the planning scans and process. Software is available to negate the need for spine fiducials. Treatment planning is a multistep process. Fiducial placement, when necessary, is performed. Next, immobilization devices (facemasks or body molds) are created, followed by computed tomography (CT) scanning, magnetic resonance imaging (MRI), or either of those procedures with angiography (CT/A and MRI/A). CT/A and MRI/A are used more commonly with vascular anomaly. Images are contoured, and physics planning follows. Our department uses radiation oncologists and surgeons. The surgeons contour treatment areas, and the physics staff plans treatments. The planning process can take as long as two weeks to allow healing time after fiducials and to achieve agreement between physics staff members and physicians. CK treatments are generally fractionated, spanning three to seven days, and fractions average 60 minutes. Patients are encouraged to take lorazepam before each fraction to foster relaxation, and they are required to take dexamethasone 4 mg after each fraction to reduce treatment-induced inflammation. Some patients receiving intracranial radiation are prescribed antiseizure medication, which is continued for at least three weeks after treatment. Providing education and support and monitoring patient status before, during, and after CK treatment are the primary roles for nursing in the CK department, as in other stereotactic radiosurgery specialties. CK treatments are a specific kind of stereotactic radiosurgery. Refer to the article in the bibliography for more information regarding stereotactic radiosurgery for intracranial tumors. Nurses ensure that patients and families understand CK planning and procedures at the time of consultation. Issues regarding claustrophobia, use of anticoagulants, and allergies to antiseizure and IV contrast agents are addressed. Education includes teaching about fiducials and pre- and post-treatment medications. On treatment days, patients are monitored for safety, and comfort measures are taken as necessary, primarily related to immobilization. Discharge teaching includes side effect management and criteria for medical intervention. Follow-up phone calls are made on post-treatment days 1 and 7. Patients are seen for follow-up 3, 6, and/or 12 months after CK. CK treatments offer advanced technology for patients. CK challenges radiation nurses with a rewarding application of knowledge and a chance to acquire new skills. Bibliography Witt, M.E., Haas, M., Marrinan, M.A., & Brown, C.N. (2003). Understanding stereotactic radiosurgery for intracranial tumors, seed implants for prostate cancer, and intravascular brachytherapy for cardiac restenosis. Cancer Nursing, 26, 494–502.
|
| Special Interest Group Newsletter March 2006 |
|
Membership Information SIG Membership Benefits
A great way to stay connected to your SIG is to join its Virtual Community. It's easy to do so. All you will need to do is
All members are encouraged to participate in their SIG's discussion forum. This area affords the opportunity for exchange of information between members and non-members on topics specific to all oncology subspecialties. Once you have your login credentials, you are ready to subscribe to your SIG's Virtual Community discussion forum. To do so
As an added feature, members are also able to register to receive their SIG's announcements—by email!
This will bring up a listing of your SIG's posted announcements. Click on My SIG's Page to view all postings in their entirety or to conclude the registration process and begin browsing.
|
| Special Interest Group Newsletter March 2006 |
|
Radiation SIG Officers
Radiation SIG Leaders
Know someone who would like to receive a print copy of this newsletter? To view past newsletters, click here. ONS Membership/Leadership Team Contact Information Angela Stengel, MS, CAE, Director of Membership/Leadership Diane Scheuring, Manager of Member Services Carol DeMarco, Membership/Leadership Administrative Assistant The Oncology Nursing Society (ONS) does not assume responsibility for the opinions expressed and information provided by authors or by Special Interest Groups (SIGs). Acceptance of advertising or corporate support does not indicate or imply endorsement of the company or its products by ONS or the SIG. Web sites listed in the SIG newsletters are provided for information only. Hosts are responsible for their own content and availability. Oncology Nursing Society
|